VIR Vir Biotechnology, Inc.

NEUTRAL Impact: 3/10 DEFA14A
Horizon immediate Filed Apr 16, 2026 Processed 1mo ago SEC 0001628280-26-025380
Proxy solicitation materials
Latest settled — T+20d
VIR ▼ -9.68% at T+20d
NEUTRAL call ✗ call lost -9.68% · α vs SPY -15.50% · entry $10.33 → $9.33
Next anchor: T+60d in 28d
Last close $8.61 (close Jun 12) · -16.65% from $10.33 entry
Entry anchored
Apr 15, 03:59 PM ET
via Databento tick
T+1d
+4.07%
call +4.07% · α +2.85%
$10.75
settled 8w ago
T+5d
+0.19%
call +0.19% · α -0.79%
$10.35
settled 8w ago
T+20d
-9.68%
call -9.68% · α -15.50%
$9.33
settled 5w ago
T+60d
call — · α —
in 28d

Price Chart

Loading chart...

Executive Summary

Vir Biotechnology filed a definitive proxy statement (DEFA14A) following the recent departure of its Chief Medical Officer, Mark Eisner. The filing is routine and does not indicate any material changes or shareholder disputes.

Actionable Insight

This is a routine filing with no immediate trading implications. Monitor for any future filings that might indicate a more significant corporate action.

Key Facts

  • Filed a DEFA14A proxy statement
  • Follows the recent departure of Chief Medical Officer Mark Eisner
  • No activist campaign or shareholder dispute mentioned
  • Filing is routine and procedural

Financial Impact

No material financial impact

Risk Factors

  • Potential for future management changes

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001628280-26-025380
Document: 0001628280-26-025380-index-headers.html0001628280-26-025380
Document: 0001628280-26-025380-index.html0001628280-26-025380
Document: 0001628280-26-025380.txt0001628280-26-025380
14 reports for VIR
Performance horizon
25% Hit rate 1 of 4 directional calls best @ T+60▲ +10.12%Feb 24, 2026
Filters
Rows
Reports for VIR — sortable, filterable
Type Now
Jun 10, 2026
4d ago
3
NEUTRAL ★ 1/10
$8.25 awaiting T+1awaiting T+1$8.61 (+4.36%)
Jun 10, 2026
4d ago
8-K
NEUTRAL ★ 2/10
$8.25 awaiting T+1awaiting T+1$8.61 (+4.36%)
Jun 2, 2026
12d ago
Insider Cluster
NEUTRAL ★ 2/10
$8.77 $9.15▲ +4.33%▲ +3.93%$8.61 (−1.82%)
May 28, 2026
17d ago
8-K
NEUTRAL ★ 2/10
$9.55 $9.54▼ −0.10%▼ −0.34%$8.61 (−9.84%)
Apr 16, 2026
8w ago
DEFA14A
NEUTRAL ★ 3/10
$10.33 $10.75▲ +4.07%▲ +2.85%$8.61 (−16.65%)
Apr 10, 2026
9w ago
8-K
NEUTRAL ★ 3/10
$9.31 $10.05▲ +7.95%▲ +6.74%$8.61 (−7.52%)
Apr 1, 2026
10w ago
Insider Cluster
BEARISH ★ 6/10
$9.02 $9.06▼ −0.44%▼ −0.36%$8.61 (+4.55%)
Mar 4, 2026
14w ago
8-K
NEUTRAL ★ 3/10
$9.10 $9.55▲ +4.95%▲ +6.26%$8.61 (−5.38%)
Feb 24, 2026
15w ago
Insider Cluster
BEARISH ★ 5/10
$9.49 $10.00▼ −5.37%▼ −4.54%$8.61 (+9.27%)
Feb 23, 2026
16w ago
Insider Cluster
BEARISH ★ 5/10
$7.43 $9.49▼ −27.73%▼ −26.99%$8.61 (−15.88%)
Showing 10 of 14

US Market Status

Market Closed — Opens in 5h

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access